Literature DB >> 7808696

Latexin: a molecular marker for regional specification in the neocortex.

Y Arimatsu1.   

Abstract

It largely remains to be elucidated how the mammalian neocortex is regionally specified during development. In an attempt to obtain molecular markers in the neocortex, we have generated a monoclonal antibody PC3.1 which recognizes a subset of neurons located in lateral, but not dorsal, neocortical areas. The antigen is a novel class of protein, named latexin, having a molecular weight of 29,000. Our in vitro studies have revealed that the neocortical regional specification for the production of latexin-positive neurons occurs very early prior to thalamocortical interactions and the completion of neurogenesis, indicating that elements intrinsic to the neocortex play important roles in the neocortical specification. Furthermore, our recent analyses have suggested that this regional specification is attributable, at least in part, to an early restriction of developmental potential in neocortical progenitor cells to become latexin-positive neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808696     DOI: 10.1016/0168-0102(94)90030-2

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  20 in total

1.  Claustrum: a case for directional, excitatory, intrinsic connectivity in the rat.

Authors:  Rena Orman
Journal:  J Physiol Sci       Date:  2015-09-02       Impact factor: 2.781

2.  Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.

Authors:  Mi Zhang; Mary Osisami; Jinlu Dai; Jill M Keller; June Escara-Wilke; Atsushi Mizokami; Evan T Keller
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

Review 3.  Aging stem cells, latexin, and longevity.

Authors:  Ying Liang; Gary Van Zant
Journal:  Exp Cell Res       Date:  2008-02-19       Impact factor: 3.905

4.  Cloning, tissue expression pattern and genomic organization of latexin, a human homologue of rat carboxypeptidase A inhibitor.

Authors:  Q Liu; L Yu; J Gao; Q Fu; J Zhang; P Zhang; J Chen; S Zhao
Journal:  Mol Biol Rep       Date:  2000       Impact factor: 2.316

5.  Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.

Authors:  Ziad J Sahab; Michael D Hall; You Me Sung; Sivanesan Dakshanamurthy; Yun Ji; Deepak Kumar; Stephen W Byers
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

6.  Differential distribution of inhibitory neuron types in subregions of claustrum and dorsal endopiriform nucleus of the short-tailed fruit bat.

Authors:  Timothy Morello; Richard Kollmar; Abdessamad Ramzaoui; Mark Stewart; Rena Orman
Journal:  Brain Struct Funct       Date:  2022-02-21       Impact factor: 3.270

7.  Identification of latexin by a proteomic analysis in rat normal articular cartilage.

Authors:  Juan B Kouri; Fidel C Hernández; Elizabeth Pérez; José L Gallegos; Leticia Cortés; Karla G Calderón; José C Luna; Febe E Cázares; María C Velasquillo
Journal:  Proteome Sci       Date:  2010-06-05       Impact factor: 2.480

8.  Clinical significance of CD146 and latexin during different stages of thyroid cancer.

Authors:  Zakaria Y Abd Elmageed; Krzysztof Moroz; Emad Kandil
Journal:  Mol Cell Biochem       Date:  2013-05-28       Impact factor: 3.396

9.  LXN deficiency regulates cytoskeleton remodelling by promoting proteolytic cleavage of Filamin A in vascular endothelial cells.

Authors:  Guozhang He; Shuang Kan; Shaohua Xu; Xuchen Sun; Rong Li; Wei Shu; Ming Chen
Journal:  J Cell Mol Med       Date:  2021-06-03       Impact factor: 5.310

Review 10.  Comparative aspects of cerebral cortical development.

Authors:  Zoltán Molnár; Christine Métin; Anastassia Stoykova; Victor Tarabykin; David J Price; Fiona Francis; Gundela Meyer; Colette Dehay; Henry Kennedy
Journal:  Eur J Neurosci       Date:  2006-02       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.